Advent Life Sciences
Venture Capital Exempt reporting adviser
Legal name: Advent Life Sciences LLP
AUM
$829.5M
Private fund assets
Private funds
7
Venture Capital 7
Private fund assets
$829.5M
Gross asset value
Employees
—
Last Form D raise
Nov 2020
Most recent fund filing
From SEC Form ADV filing (filed Mar 26, 2026). View on SEC
Investment focus
As listed in industry directories; may be out of date.
- Stages
- Series AGrowth
- Sectors
- Life Sciences & Healthtech
- Geographies
- United Kingdom
People(4)
Owners and executive officers named on the firm's SEC Form ADV.
D
M
R
S
Funds(7)
Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.
| Fund | Type | Gross assets | Raised (Form D) | Investors | Last Form D | Recency |
|---|---|---|---|---|---|---|
| Advent-Harrington Impact Fund LP | Venture Capital | $52.2M | $41.6M | 33 | Nov 2020 | Cold |
| Advent Life Sciences Fund III LP | Venture Capital | $154.1M | $24.8M | 3 | Dec 2019 | Cold |
| Advent Life Sciences Fund II LP | Venture Capital | $159.2M | $226.3M | 15 | Nov 2014 | Cold |
| Advent Life Sciences Fund I LP | Venture Capital | $246.7M | — | — | — | |
| Advent Life Sciences Growth Fund LP | Venture Capital | $170.8M | — | — | — | |
| Biomotiv LLC | Venture Capital | $27.9M | — | — | — | |
| Advent Life Sciences II Co-Invest LP | Venture Capital | $18.6M | — | — | — |
Board seats
Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.
No board seats matched from SEC filings yet.
Regulatory identifiers
- CRD number
- 173031
- SEC file number
- 802-92178
Sources
- SEC Form ADV Oct 14, 2026